Final answer:
The meningitis vaccination schedule for individuals who are immunocompromised can vary depending on the specific condition and recommendations from healthcare professionals. The CDC recommends a quadrivalent vaccine for children between 11-12 years of age, with a booster at age 16. Additional booster doses or vaccinations may be given to individuals in high-risk settings.
Step-by-step explanation:
The meningitis vaccination schedule for individuals who are immunocompromised can vary depending on the specific condition and recommendations from healthcare professionals. However, the Centers for Disease Control and Prevention (CDC) recommends that children between 11-12 years of age receive a quadrivalent vaccine that protects against serotypes A, C, W, and Y, with a booster at age 16. This vaccine helps protect against meningococcal meningitis, which is caused by Neisseria meningitidis. Additionally, individuals in high-risk settings, such as during epidemic outbreaks or those living in close quarters, may receive additional booster doses or vaccinations.